Bug Fixes
FOR EU/EEA HEALTHCARE PROFESSIONALS ONLY
Celgene Corporation would like to introduce an EU / EEA mobile dosing app for ABRAXANE® (paclitaxel formulated as albumin bound nanoparticles). Recommended doses and modifications for both EU / EEA approved indications for ABRAXANE can be found within this mobile app. The dosing recommendations are based on the Prescribing Information for ABRAXANE. Also included is an overview of the trial design for each indication, including treatment arms, study dose, and patient population.
Please see full Prescribing Information, including Boxed WARNING for ABRAXANE at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000778/WC500020435.pdf
This App is not a medical device, but intended for use as an educational tool.
©2014 Celgene Corporation. All rights reserved. Date of preparation May 2014.
This version of EU Dosing App Android App comes with one universal variant which will work on all the Android devices.
If you are looking to download other versions of EU Dosing App Android App, We have 1 version in our database. Please select one of them below to download.